Orgovyx 120 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FYQVW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,386
Award facts
- Contract value 100% obligated
- $1,385.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) on September 15, 2025, with completion targeted for October 6, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating competitive award. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company demonstrates extensive capability in fulfilling federal medical supply requirements through its portfolio of delivery orders covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The firm fixed-price delivery order structure allows the company to efficiently fulfill specific medical commodity needs while maintaining operational flexibility under the overarching DLA framework.
Quick answers
Who was awarded contract SPE2DB25FYQVW?
SPE2DB25FYQVW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FYQVW worth?
The government has obligated $1,386 on SPE2DB25FYQVW.
Is contract SPE2DB25FYQVW an order under another contract?
Yes. SPE2DB25FYQVW is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQVW competed?
The extent of competition for SPE2DB25FYQVW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award